Abstract
In a retrospective case–control study, we investigated high-risk HPV DNA presence by general primer GP5+/6+ PCR in the last normal cervical smear in the patient archives (i.e. baseline smear) of 57 women who later developed cervical cancer. Also, normal cervical smears of 114 age-matched control women were analysed. High-risk HPV DNA was detected in 37 of the 57 (65%) baseline smears of the case women, and 7 (6%) of 114 smears of the control women (OR 28, 95% Cl 11–72). The HPV positive subsequent smears and cervical cancer biopsies of the case women contained the same HPV type as was detected in the baseline smear. After cytological revision, the baseline smears of 48 case women (84%) were reclassified as abnormal, 33 (69%) of which scored high-risk HPV DNA positive. Ultimately, an undisputable normal baseline smear was found in only 10 case women. In 7 (70%) of them this smear was HPV positive, whereas only 7 (7%) of 104 revised, undisputable normal smears of control women were high-risk HPV positive (OR 32, 95% Cl 6.8–153). The results showed that (1) high-risk HPV presence precedes abnormal cytology in women who develop cervical cancer, and (2) high-risk HPV testing signals false-negative smears of women at risk of cervical cancer. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796–802
Cuzick J, Terry G, Ho L, Monaghan J, Lopes A, Clarkson P and Duncan I (2000) Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 82: 1348–1352
De Roda Husman A-M, Walboomers JMM, Meijer CJLM, Risse EKJ, Schipper MEI, Helmerhorst THJM, Bleker OP, Delius H, van den Brule AJC and Snijders PJF (1994) Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer 56: 802–806
Ho GYF, Bierman R, Beardsley L, Chang CJ and Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423–428
Hopman EH, Rozendaal L, Voorhorst FJ, Walboomers JMM, Kenemans P and Helmerhorst THJM (2000) High risk HPV in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy. BJ Obstet Gynaecol 107: 600–604
IARC (1995) Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses 64, Lyon: International Agency for Research on Cancer
Jacobs MV, Snijders PJF, van den Brule AJC, Helmerhorst THJM, Meijer CJLM and Walboomers JMM (1997) A general primer GP5+/GP6+ mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 35: 791–795
Jacobs MV, Zielinski GD, Meijer CJLM, Pol RP, Voorhorst FJ, de Schipper FA, Runsink AP, Snijders PJF and Walboomers JMM (2000) A simplified and reliable HPV testing of archival Papaniculaou-stained archival smears: application to cervical smears from cancer patients starting with cytologically normal smears. Br J Cancer 82: 1421–1426
Josefsson AM, Magnusson PKE, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Kragh Andersen P, Melbeye M, Adami HO and Gyllensten UB (2000) Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2189–2193
Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D and Kiviat NB (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327: 1272–1278
Meijer CJLM, Rozendaal L, Van der Linden JC, Helmerhorst THJM, Voorhorst FJ and Walboomers JMM (1997) Human papillomavirus testing for primary cervical cancer screening. Franco E, Monsonego J (eds). New developments in cervical cancer screening and prevention, Oxford: Blackwell Science 338–347
Melkert PWJ, Hopman E, Van den Brule AJC, Risse EKJ, Van Diest PJV, Bleker OP, Helmerhorst T, Schipper MEI, Meijer CJLM and Walboomers JMM (1993) Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age dependent. Int J Cancer 53: 919–923
Nobbenhuis MAE, Walboomers JMM, Helmerhorst THJM, Rozendaal L, Remmink AJ, Risse EK, Van der Linden JC, Voorhorst FJ, Kenemans P and Meijer CJLM (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354: 20–25
Robertson JH and Woodend B (1993) Negative cytology preceding cervical cancer: causes and prevention. J Clin Pathol 46: 700–702
Rozendaal L, Walboomers JMM, Van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst THJM, van Ballegooijen M and Meijer CJLM (1996) PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 68: 766–769
Vooijs GP (1987) De advisering bij afwijkende bevindingen van cytologisch onderzoek van de cervix uteri. Ned Tijdschr Geneeskd 131: 1662–1663
Walboomers JMM, De Roda Husman A-M, Snijders PJF, Stel HV, Risse EKJ, Helmerhorst THJM, Voorhorst FJ and Meijer CJLM (1995) Human papillomavirus testing in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol 48: 728–732
Walboomers JMM, Jacobs MV, Van Oostveen JW, Van den Brule AJC, Snijders PJF and Meijer CJLM (1997) Detection of genital HPV infections and possible clinical implication. Gross G, Von Krogh G (eds) Human papillomavirus in dermatovenereology, New York: CRC Press, Boca Raton pp. 341–364
Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM and Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19
Wallin KL, Wiklund F, Angström T, Bergman F, Stendahl U, Wadell G, HAllmans G and Dillner J (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341: 1633–1638
Ytitalo N, Josefsson A, Melbye M, Sörensen P, Frisch M, Kragh Andersen P, Sparén P, Gustafsson M, Magnusson P, Pontén J, Gyllensten U and Adami H-O (2000a) Prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res 60: 6027–6032
Ylitalo N, Sorensen P, Josefsson AM, Magnusson PKE, Kragh Andersen P, Pontén J, Adami HO & Gyllenstenuo Melbye M (2000b) Consistent high viral load of human papilloma virus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355: 2194–2198
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Zielinski, G., Snijders, P., Rozendaal, L. et al. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 85, 398–404 (2001). https://doi.org/10.1054/bjoc.2001.1926
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1926
Keywords
This article is cited by
-
Therapeutic HPV Vaccination: A Strategy for Cervical Cancer Elimination in India
Indian Journal of Gynecologic Oncology (2024)
-
Zervixkarzinom
Die Onkologie (2023)
-
Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis
Oncogene (2013)
-
A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science
Archives of Gynecology and Obstetrics (2011)
-
Spectral cytopathology of cervical samples: detecting cellular abnormalities in cytologically normal cells
Laboratory Investigation (2010)